Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358–78.
Article CAS PubMed PubMed Central Google Scholar
Kuzmin DA, Shutova MV, Johnston NR, Smith OP, Fedorin VV, Kukushkin YS, et al. The clinical landscape for AAV gene therapies. Nat Rev Drug Discov. 2021;20:173–4.
Article CAS PubMed Google Scholar
Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an AAV vector expressing human SMN. Hum Gene Ther. 2018;29:285–98.
Article CAS PubMed PubMed Central Google Scholar
Hordeaux J, Wang Q, Katz N, Buza EL, Bell P, Wilson JM. The neurotropic properties of AAV-PHP.B are limited to C57BL/6J mice. Mol Ther. 2018;26:664–8.
Article CAS PubMed PubMed Central Google Scholar
Hordeaux J, Buza EL, Dyer C, Goode T, Mitchell TW, Richman L, et al. Adeno-associated virus-induced dorsal root ganglion pathology. Hum Gene Ther. 2020;31:808–18.
Article CAS PubMed Google Scholar
Agarwal S. High-dose AAV gene therapy deaths. Nat Biotechnol. 2020;38:910.
Kishimoto TK, Samulski RJ. Addressing high dose AAV toxicity—“one and done” or “slower and lower”? Expert Opin Biol Ther. 2022;22:1067–71.
Hingorani M, Hanson I, van Heyningen V. Aniridia. Eur J Hum Genet. 2012;20:1011–7.
Article CAS PubMed PubMed Central Google Scholar
Shortt AJ, Bunce C, Levis HJ, Blows P, Dore CJ, Vernon A, et al. Three-year outcomes of cultured limbal epithelial allografts in Aniridia and Stevens-Johnson Syndrome evaluated using the clinical outcome assessment in surgical trials assessment tool. Stem Cells Transl Med. 2014;3:265–75.
Article CAS PubMed PubMed Central Google Scholar
Ramaesh K, Ramaesh T, Dutton GN, Dhillon B. Evolving concepts on the pathogenic mechanisms of aniridia related keratopathy. Int J Biochem Cell Biol. 2005;37:547–57.
Article CAS PubMed Google Scholar
Mort RL, Bentley AJ, Martin FL, Collinson JM, Douvaras P, Hill RE, et al. Effects of aberrant Pax6 gene dosage on mouse corneal pathophysiology and corneal epithelial homeostasis. PLoS One. 2011;6:e28895.
Article CAS PubMed PubMed Central Google Scholar
Li G, Xu F, Zhu J, Krawczyk M, Zhang Y, Yuan J, et al. Transcription factor PAX6 (Paired Box 6) controls limbal stem cell lineage in development and disease. J Biol Chem. 2015;290:20448–54.
Article CAS PubMed PubMed Central Google Scholar
Ramaesh T, Ramaesh K, Martin Collinson J, Chanas SA, Dhillon B, West JD. Developmental and cellular factors underlying corneal epithelial dysgenesis in the Pax6+/- mouse model of aniridia. Exp Eye Res. 2005;81:224–35.
Article CAS PubMed Google Scholar
Hickmott JW, Gunawardane U, Jensen K, Korecki AJ, Simpson EMA. Epistasis between PAX6Sey and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials. Gene Ther. 2018;25:524–37.
Article CAS PubMed PubMed Central Google Scholar
Davis J, Duncan MK, Robison WG Jr, Piatigorsky J. Requirement for Pax6 in corneal morphogenesis: a role in adhesion. J Cell Sci. 2003;116:2157–67.
Article CAS PubMed Google Scholar
Ramaesh T, Collinson JM, Ramaesh K, Kaufman MH, West JD, Dhillon B. Corneal abnormalities in Pax6+/- small eye mice mimic human aniridia-related keratopathy. Investig Ophthalmol Vis Sci. 2003;44:1871–8.
Mort RL, Douvaras P, Morley SD, Dora N, Hill RE, Collinson JM, et al. Stem cells and corneal epithelial maintenance: insights from the mouse and other animal models. Results Probl Cell Differ. 2012;55:357–94.
Article PubMed PubMed Central Google Scholar
Colon-Thillet R, Jerome KR, Stone D. Optimization of AAV vectors to target persistent viral reservoirs. Virol J. 2021;18:85.
Article CAS PubMed PubMed Central Google Scholar
Sabatino DE, Bushman FD, Chandler RJ, Crystal RG, Davidson BL, Dolmetsch R, et al. Evaluating the state of the science for adeno-associated virus integration: an integrated perspective. Mol Ther. 2022;30:2646–63.
Article CAS PubMed Google Scholar
Becker J, Fakhiri J, Grimm D. Fantastic AAV gene therapy vectors and how to find them-random diversification, rational design and machine learning. Pathogens. 2022;11:756.
Article CAS PubMed PubMed Central Google Scholar
Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol. 2009;27:59–65.
Article CAS PubMed Google Scholar
Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR, et al. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther. 2012;23:382–9.
Article CAS PubMed Google Scholar
Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A, et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol. 2016;34:204–9.
Article CAS PubMed PubMed Central Google Scholar
Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci. 2017;20:1172–9.
Article CAS PubMed PubMed Central Google Scholar
Huang Q, Chan KY, Tobey IG, Chan YA, Poterba T, Boutros CL, et al. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS One. 2019;14:e0225206.
Article CAS PubMed PubMed Central Google Scholar
Hordeaux J, Yuan Y, Clark PM, Wang Q, Martino RA, Sims JJ, et al. The GPI-linked protein LY6A drives AAV-PHP.B transport across the blood-brain barrier. Mol Ther. 2019;27:912–21.
Article CAS PubMed PubMed Central Google Scholar
Matsuzaki Y, Tanaka M, Hakoda S, Masuda T, Miyata R, Konno A, et al. Neurotropic properties of AAV-PHP.B are shared among diverse inbred strains of mice. Mol Ther. 2019;27:700–4.
Article CAS PubMed PubMed Central Google Scholar
Matsuzaki Y, Konno A, Mochizuki R, Shinohara Y, Nitta K, Okada Y, et al. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain. Neurosci Lett. 2018;665:182–8.
Article CAS PubMed Google Scholar
Liguore WA, Domire JS, Button D, Wang Y, Dufour BD, Srinivasan S, et al. AAV-PHP.B administration results in a differential pattern of CNS biodistribution in non-human primates compared with mice. Mol Ther. 2019;27:2018–37.
Article CAS PubMed PubMed Central Google Scholar
Gyorgy B, Meijer EJ, Ivanchenko MV, Tenneson K, Emond F, Hanlon KS, et al. Gene transfer with AAV9-PHP.B rescues hearing in a mouse model of usher syndrome 3A and transduces hair cells in a non-human primate. Mol Ther Methods Clin Dev. 2019;13:1–13.
Article CAS PubMed Google Scholar
Taiber S, Cohen R, Yizhar-Barnea O, Sprinzak D, Holt JR, Avraham KB. Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness. EMBO Mol Med. 2021;13:e13259.
Article CAS PubMed Google Scholar
Shubina-Oleinik O, Nist-Lund C, French C, Rockowitz S, Shearer AE, Holt JR. Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss. Sci Adv. 2021;7:eabi7629.
Article CAS PubMed PubMed Central Google Scholar
Chen YA, Kankel MW, Hana S, Lau SK, Zavodszky MI, McKissick O, et al. In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model. Gene Ther. 2022:1–12. https://doi.org/10.1038/s41434-022-00375-w.
Wu J, Solanes P, Nist-Lund C, Spataro S, Shubina-Oleinik O, Marcovich I, et al. Single and dual vector gene therapy with AAV9-PHP.B rescues hearing in Tmc1 mutant mice. Mol Ther. 2021;29:973–88.
Article CAS PubMed Google Scholar
Hana S, Peterson M, McLaughlin H, Marshall E, Fabian AJ, McKissick O, et al. Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice. Gene Ther. 2021;28:646–58.
留言 (0)